Helios (HLIO) Form 3 Shows Executive Options, Performance RSUs

Rhea-AI Filing Summary

Jeremy Scott Evans filed an initial Form 3 disclosing beneficial ownership in Helios Technologies, Inc. (HLIO). He directly owns 195 shares of common stock and holds multiple equity awards: stock options to purchase 2,671 and 2,118 shares $40.13 and $39.80), performance-based restricted stock units potentially covering up to 836 shares, and several time-based restricted stock unit grants totaling 2,295 RSUs across grant dates in 2024–2025. Vesting and exercise schedules vary: some options vest fully on the third anniversary, performance awards depend on multi-year metrics, and RSUs vest over one-to-three year schedules. The filing includes a remark that the submission was delayed due to obtaining EDGAR Next credentials.

Positive

• Officer holds meaningful equity-based compensation (options and RSUs) aligning incentives with long-term shareholder value
• Performance awards include upside multipliers (up to 225% for performance options and up to 200% for performance RSUs), linking pay to multi-year metrics

Negative

• Form filing was delayed due to administrative issues obtaining EDGAR Next credentials, which could concern timely disclosure practices

Insights

Corporate Governance Expert

TL;DR: Routine insider disclosure showing officer equity holdings and standard vesting; delayed filing noted but no adverse corporate governance signals in the filing itself.

The Form 3 documents the Chief Accounting Officer's direct ownership of 195 shares and a portfolio of time- and performance-based awards that align his compensation with long-term company performance. Vesting schedules span one to three years and performance awards are tied to committee-approved metrics, indicating governance oversight of incentive design. The delayed filing is disclosed as administrative and lacks further explanation here.

Compensation Analyst

TL;DR: Officer compensation is largely equity-based with mix of time-vested and performance-contingent awards, typical for alignment with shareholder interests.

The disclosure quantifies option grants (2,671 and 2,118 options) with exercise prices near $40 and multiple RSU grants (836 performance-based plus 2,295 time-based RSUs). Performance awards include upside multipliers

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Evans Jeremy Scott

(Last) (First) (Middle)

C/O HELIOS TECHNOLOGIES, INC.

7456 16TH ST E

(Street)

SARASOTA FL 34243

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/01/2025

3. Issuer Name and Ticker or Trading Symbol
HELIOS TECHNOLOGIES, INC. [ HLIO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	195	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	09/11/2027(1)	09/11/2034(1)	Common Stock	2,671	$40.13	D
Stock Options (right to buy)	03/15/2028(2)	02/27/2035(2)	Common Stock	2,118	$39.8	D
Performance-Based Restricted Stock Units	(3)	(3)	Common Stock	836	$0	D
Restricted Stock Units	(4)	(4)	Common Stock	557	$0(5)	D
Restricted Stock Units	(6)	(6)	Common Stock	748	$0(5)	D
Restricted Stock Units	(7)	(7)	Common Stock	990	$0(5)	D

Explanation of Responses:

1. Stock Options granted to reporting person on September 11, 2024; unless earlier forfeited under the terms of the Options, 100% of the options vest and become exercisable on the third anniversary of the grant date.

2. The performance stock options granted to the reporting person on February 27, 2025, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2025 and ending the last day of the fiscal year of 2027, subject to continuous employment with the Company through March 15, 2028. Stock options expire 10 years from the date of grant.

3. The performance based restricted stock units granted to the reporting person on April 1, 2024, which represent the right to receive, following vesting, up to 200% of one share of the Company's Common Stock. The number of shares of Common Stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee over a three-year performance period beginning on the first day of the fiscal year of 2024 and ending on the last day of the fiscal year of 2027.

4. Restricted stock units granted to reporting person on April 1, 2024; unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date.

5. Each RSU represents the right to receive, following vesting, one share of Common Stock.

6. Restricted stock units granted to reporting person on September 11, 2024, 50% of the awards vest and convert into Common Stock on each of the first two anniversaries of the grant date.

7. Restricted stock units granted to reporting person on February 17, 2025; unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of the first three anniversaries of the grant date.

Remarks:

Ex. 24.1 Power of Attorney; The filing was delayed due to delays in obtaining valid filing credentials from EDGAR Next.

	/s/ Marc Greenberg, Attorney-in-Fact for Jeremy Scott Evans	09/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jeremy Scott Evans report on the Form 3 for HLIO?

The Form 3 reports 195 shares owned directly and multiple equity awards including 2,671 and 2,118 stock options and performance/time-based RSUs totaling 3,131 potential shares disclosed.

What are the key vesting or exercise terms disclosed?

Some options vest 100% on the third anniversary; performance options and RSUs vest based on multi-year performance metrics; certain RSUs vest in equal installments over one-to-three years.

What are the exercise prices for the disclosed stock options?

The filing shows exercise prices of $40.13 for 2,671 options and $39.80 for 2,118 performance stock options.

Are the performance awards contingent on company results?

Yes. Performance-based awards vest contingent on pre-established performance metrics approved by the Compensation Committee over specified three-year performance periods.

Was there anything notable about the timing of the filing?

Yes. The filing notes a delay attributed to obtaining valid EDGAR Next credentials; no further explanation is provided in the document.